India flags testing lapses at pharma firms after cough syrups deaths

Indias drug regulator has flagged testing failures at pharmaceutical firms after 17 children died from toxic cough syrups, raising serious concerns about medication safety.

• The Indian drug regulator revealed that several pharmaceutical companies did not adhere to mandatory testing protocols for every batch of medicinal ingredients.
• Seventeen children in Madhya Pradesh died last month due to cough syrups containing diethylene glycol, a toxic substance linked to the medications production.
• Authorities are now investigating the production practices of firms in Gujarat and other regions to ensure compliance with safety regulations for cold medicine.